CD69: An unexpected regulator of TH17 cell-driven inflammatory responses

Science Signaling

Volumn 4, Issue 165, 2011, Pages

  Martín, Pilar ^a   Sánchez Madrid, Francisco ^a,b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; INTERLEUKIN 17; LECTIN RECEPTOR; MYOSIN HEAVY CHAIN ALPHA; TRANSFORMING GROWTH FACTOR BETA; LECTIN; LEUKOCYTE ANTIGEN; STAT5 PROTEIN; T LYMPHOCYTE ANTIGEN;

ALLERGIC ASTHMA; ARTHRITIS; DERMATITIS; HELPER CELL; INFLAMMATION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; GENETICS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; REGULATORY T LYMPHOCYTE; TH17 CELL;

MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LECTINS, C-TYPE; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 79953076438     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2001825     Document Type: Review

References (36)

1. I. I. Ivanov, B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, D. R. Littman, The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
2. T. J. Harris, J. F. Grosso, H. R. Yen, H. Xin, M. Kortylewski, E. Albesiano, E. L. Hipkiss, D. Getnet, M. V. Goldberg, C. H. Maris, F. Housseau, H. Yu, D. M. Pardoll, C. G. Drake, Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179, 4313-4317 (2007).
3. X. O. Yang, A. D. Panopoulos, R. Nurieva, S. H. Chang, D. Wang, S. S. Watowich, C. Dong, STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358-9363 (2007).
4. A. Laurence, C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, E. M. Shevach, J. J. O'shea, Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
5. B. Stockinger, Good for goose, but not for gander: IL-2 interferes with Th17 differentiation. Immunity 26, 278-279 (2007).
6. M. López-Cabrera, A. G. Santis, E. Fernández-Ruiz, R. Blacher, F. Esch, P. Sánchez-Mateos, F. Sánchez-Madrid, Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178, 537-547 (1993).
7. R. Testi, D. D'Ambrosio, R. De Maria, A. Santoni, The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15, 479-483 (1994).
8. A. Zingoni, G. Palmieri, S. Morrone, M. Carretero, M. Lopez-Botel, M. Piccoli, L. Frati, A. Santoni, CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor. Eur. J. Immunol. 30, 644-651 (2000).
9. R. Testi, J. H. Phillips, L. L. Lanier, T cell activation via Leu-23 (CD69). J. Immunol. 143, 1123-1128 (1989).
10. M. Cebrián, E. Yagüe, M. Rincón, M. López-Botet, M. O. de Landázuri, F. Sánchez-Madrid, Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168, 1621-1637 (1988).
11. D. Sancho, M. Gómez, F. Viedma, E. Esplugues, M. Gordón-Alonso, M. A. García-López, H. de la Fuente, C. Martínez-A, P. Lauzurica, F. Sánchez-Madrid, CD69 downregulates autoimmune reactivity through active transforming growth factorbeta production in collagen-induced arthritis. J. Clin. Investig. 112, 872-882 (2003).
12. M. E. Brandes, J. B. Allen, Y. Ogawa, S. M. Wahl, Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Investig. 87, 1108-1113 (1991).
13. A. O'Garra, P. Vieira, Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801-805 (2004).
14. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, V. K. Kuchroo, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
15. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, B. Stockinger, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
16. K. Murata, M. Inami, A. Hasegawa, S. Kubo, M. Kimura, M. Yamashita, H. Hosokawa, T. Nagao, K. Suzuki, K. Hashimoto, H. Shinkai, H. Koseki, M. Taniguchi, S. F. Ziegler, T. Nakayama, CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int. Immunol. 15, 987-992 (2003).
17. A. Lamana, D. Sancho, A. Cruz-Adalia, G. M. del Hoyo, A. M. Herrera, M. Feria, F. Díaz-González, M. Gómez, F. Sánchez- Madrid, The role of CD69 in acute neutrophil-mediated inflammation. Eur. J. Immunol. 36, 2632-2638 (2006).
18. D. Sancho, M. Gómez, G. Martinez Del Hoyo, A. Lamana, E. Esplugues, P. Lauzurica, C. Martinez-A, F. Sánchez-Madrid, CD69 targeting differentially affects the course of collagen-induced arthritis. J. Leukoc. Biol. 80, 1233-1241 (2006).
19. P. Martín, M. Gómez, A. Lamana, A. Cruz-Adalia, M. Ramírez-Huesca, M. A. Ursa, M. Yáñez-Mo, F. Sánchez-Madrid, CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol. Cell. Biol. 30, 4877-4889 (2010).
20. P. Martín, M. Gómez, A. Lamana, A. M. Matesanz Marín, J. R. Cortés, M. Ramírez-Huesca, O. Barreiro, P. López-Romero, C. Gutiérrez-Vázquez, H. de la Fuente, A. Cruz-Adalia, F. Sánchez-Madrid, The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. J. Allergy Clin. Immunol. 126, 355-365, 365, e1-e3 (2010).
21. A. Cruz-Adalia, L. J. Jiménez-Borreguero, M. Ramírez- Huesca, I. Chico-Calero, O. Barreiro, E. López-Conesa, M. Fresno, F. Sánchez-Madrid, P. Martín, CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Circulation 122, 1396-1404 (2010).
22. T. Miki-Hosokawa, A. Hasegawa, C. Iwamura, K. Shinoda, S. Tofukuji, Y. Watanabe, H. Hosokawa, S. Motohashi, K. Hashimoto, M. Shirai, M. Yamashita, T. Nakayama, CD69 controls the pathogenesis of allergic airway inflammation. J. Immunol. 183, 8203-8215 (2009).
23. S. Ishikawa, S. Akakura, M. Abe, K. Terashima, K. Chijiiwa, H. Nishimura, S. Hirose, T. Shirai, A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: Possible abnormal regulatory role for cytokine imbalance. J. Immunol. 161, 1267-1273 (1998).
24. Y. Han, Q. Guo, M. Zhang, Z. Chen, X. Cao, CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J. Immunol. 182, 111-120 (2009).
25. T. R. Radstake, L. van Bon, J. Broen, M. Wenink, K. Santegoets, Y. Deng, A. Hussaini, R. Simms, W. W. Cruikshank, R. Lafyatis, Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS ONE 4, e5981 (2009).
26. E. Martín-Gayo, E. Sierra-Filardi, A. L. Corbí, M. L. Toribio, Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115, 5366-5375 (2010).
27. L. R. Shiow, D. B. Rosen, N. Brdicková, Y. Xu, J. An, L. L. Lanier, J. G. Cyster, M. Matloubian, CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540-544 (2006).
28. J. Rivera, R. L. Proia, A. Olivera, The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat. Rev. Immunol. 8, 753-763 (2008).
29. M. C. Huang, S. R. Watson, J. J. Liao, E. J. Goetzl, Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol. 178, 6806-6813 (2007).
30. G. Liu, S. Burns, G. Huang, K. Boyd, R. L. Proia, R. A. Flavell, H. Chi, The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769-777 (2009).
31. A. J. Bankovich, L. R. Shiow, J. G. Cyster, CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J. Biol. Chem. 285, 22328-22337 (2010).
32. N. Czeloth, G. Bernhardt, F. Hofmann, H. Genth, R. Förster, Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 175, 2960-2967 (2005).
33. A. Lamana, P. Martin, H. de la Fuente, L. Martinez-Munoz, A. Cruz-Adalia, M. Ramirez-Huesca, C. Escribano, K. Gollmer, M. Mellado, J. V. Stein, J. L. Rodriguez-Fernandez, F. Sanchez-Madrid, G. Martinez Del Hoyo, CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. J. Invest. Dermatol. (2011); 10.1038/jid.2011.54.
34. T. Okazaki, I. M. Okazaki, J. Wang, D. Sugiura, F. Nakaki, T. Yoshida, Y. Kato, S. Fagarasan, M. Muramatsu, T. Eto, K. Hioki, T. Honjo, PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. J. Exp. Med. 208, 395-407 (2011).
35. K. J. Scalapino, D. I. Daikh, CTLA-4: A key regulatory point in the control of autoimmune disease. Immunol. Rev. 223, 143-155 (2008).
36. Acknowledgments: We thank R. González-Amaro, D. Sancho, J. L. Rodríguez, and S. Bartlett for comments and critical reading of the manuscript. Funding: This work was supported by grant SAF2008-02719 from the Spanish Ministry of Science and Innovation (MICINN) to P.M. and grants SAF2008-02635 (MICINN) and INSINET 01592006 [Comunidad de Madrid (FONCICYTC002-2009-1ALA/127249)] and a MEICA award (Genoma España) to F.S.-M. P.M. holds a MICINN "Ramón y Cajal" contract (RYC-2006). The CNIC is supported by the MICINN and the Pro CNIC Foundation.